News
I don’t know what the heck is going to come out,” the German supermodel, 52, confessed about her worm and parasite cleanse.
Here are four kinds of ticks — and the diseases they potentially carry — to watch out for: ...
As transmission patterns shift and vulnerability deepens, tackling dengue’s structural inequities can involve collaborative, ...
Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given.
Carta Healthcare, a leading provider of AI-powered clinical data abstraction, has been named the winner of a Silver Stevie® Award in the Technical Innovation of the Year category in the second annual ...
In their zeal to “Make America Healthy Again,” Trump administration officials are making statements that some advocacy and ...
The Mpox outbreak has renewed interest in Kenya from various foreign vaccine suppliers. One of the few WHO-approved Mpox ...
Portions of research and clinical trials have ground to a halt. Labs have been instructed to scrutinize every expense, from equipment to personnel. Some teams are even killing off lab mice because ...
Praxis Precision Medicines’ oral vormatrigine stopped 100% of seizures in 22% of patients in a Phase II trial. The RADIANT ...
Phase 3 VELA program in hidradenitis suppurativa (HS) on track for an expected primary endpoint readout around September 2025 and an expected submission of a Biologic License Application (BLA) in the ...
Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results